In the BioHarmony Drug Report Database

"Preview" Icon

Rasburicase

Elitek, Fasturtec (rasburicase) is an enzyme pharmaceutical. Rasburicase was first approved as Elitek on 2001-02-23. It is used to treat hyperuricemia and tumor lysis syndrome in the USA. It has been approved in Europe to treat hyperuricemia.

 

Trade Name

 

Fasturtec
 

Common Name

 

rasburicase
 

ChEMBL ID

 

CHEMBL1201594
 

Indication

 

hyperuricemia, tumor lysis syndrome
 

Drug Class

 

Enzymes

Image (chem structure or protein)

Rasburicase structure rendering